Supplementary Data from Genetic Modulation of <i>BET1L</i> Confers Colorectal Cancer Susceptibility by Reducing miRNA Binding and m⁶A Modification per Shuwei Li (16437116)

Supplementary Table S2 from Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma per Phyllis S.Y. Chong (17141520)

Matèries:

Supplementary Table S1 from Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma per Phyllis S.Y. Chong (17141520)

Matèries:

Supplementary Data 4 from Targeting KDM2A Enhances T-cell Infiltration in NSD1-Deficient Head and Neck Squamous Cell Carcinoma per Chen Chen (16799528)

Matèries:

Supplementary Data 1 from Targeting KDM2A Enhances T-cell Infiltration in NSD1-Deficient Head and Neck Squamous Cell Carcinoma per Chen Chen (16799528)

Matèries:

Supplementary Data 3 from Targeting KDM2A Enhances T-cell Infiltration in NSD1-Deficient Head and Neck Squamous Cell Carcinoma per Chen Chen (16799528)

Matèries:

Taming the Piers–Rubinsztajn Reaction: Beyond B(C₆F₅)₃ per David R. Wilson (6243272)

Matèries:

Supplementary Table S4 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma per Mengjie Zhao (14845174)

Matèries:

Supplementary Table S5 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma per Mengjie Zhao (14845174)

Matèries:

Supplementary Table S2 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma per Mengjie Zhao (14845174)

Matèries:

Supplementary Table S8 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma per Mengjie Zhao (14845174)

Matèries:

Supplementary Table S1 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma per Mengjie Zhao (14845174)

Matèries:

Supplementary Figure S6 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX per Rumani Singh (17141575)

Matèries:

Supplementary Figure S3 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX per Rumani Singh (17141575)

Matèries:

Supplementary Figure S5 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX per Rumani Singh (17141575)

Matèries:

Supplementary Figure S2 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX per Rumani Singh (17141575)

Matèries:

Supplementary Figure S4 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX per Rumani Singh (17141575)

Matèries:

Supplementary Figure S1 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX per Rumani Singh (17141575)

Matèries:

Supplementary Table S3 from A Therapeutically Targetable NOTCH1–SIRT1–KAT7 Axis in T-cell Leukemia per Olga Lancho (15125854)

Matèries:

Supplementary Table S1 from A Therapeutically Targetable NOTCH1–SIRT1–KAT7 Axis in T-cell Leukemia per Olga Lancho (15125854)

Matèries: